Patents by Inventor Tim Owens

Tim Owens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10929208
    Abstract: Methods and apparatus for extracting information corresponding to a user selected area of a displayed web page are described. A user selected region, e.g., rectangular region, of a displayed web page is identified based on received user input. The elements beneath the user selected region are converted to a raster data URL. An HTML5 image element is created with an src attribute set to the raster data URL and with a low image element opacity property. The created HTML5 image element is added to the web page as an overlay. The web browser's built-in copying functionality can now be used to copy the overlying image element to the clipboard as an image as desired, e.g., using a context menu which enables image MIME type data to be placed on the clipboard.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: February 23, 2021
    Assignee: Accusoft Corporation
    Inventors: Kiril Vatev, Cody Owens, Stephen Brooks, Eric Goebel, Adam Cooper, Tim Kannapel
  • Publication number: 20200190092
    Abstract: The present disclosure provides compounds of Formula (IA) and/or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: December 9, 2019
    Publication date: June 18, 2020
    Applicant: PRINCIPIA BIOPHARMA INC.
    Inventors: Tim OWENS, Erik VERNER
  • Patent number: 10533013
    Abstract: The present disclosure provides compounds of Formula (IA), such as, e.g., (R)-2-(3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile having the chemical structure ?and/or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK inhibitors, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: January 14, 2020
    Assignee: Principia Biopharma Inc.
    Inventors: Tim Owens, Erik Verner
  • Publication number: 20180327413
    Abstract: The present disclosure provides compounds of Formula (IA) and/or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 11, 2018
    Publication date: November 15, 2018
    Applicant: PRINCIPIA BIOPHARMA INC.
    Inventors: Tim OWENS, Erik VERNER
  • Patent number: 9994576
    Abstract: The present disclosure provides compounds of Formula (II) as disclosed herein, and/or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK inhibitors, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: June 12, 2018
    Assignee: PRINCIPIA BIOPHARMA INC.
    Inventors: Tim Owens, Erik Verner
  • Patent number: 9676778
    Abstract: The present disclosure provides compounds of formula (I) wherein the variables are as defined herein that are JAK3 inhibitors and therefore useful for the treatment of diseases treatable by inhibition of JAK3 such as cancer and inflammatory diseases. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: June 13, 2017
    Assignee: PRINCIPIA BIOPHARMA INC.
    Inventors: David Michael Goldstein, Kenneth Albert Brameld, Tim Owens
  • Publication number: 20160251358
    Abstract: The present disclosure provides compounds of Formula (IA) and/or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: January 15, 2016
    Publication date: September 1, 2016
    Applicant: PRINCIPIA BIOPHARMA INC.
    Inventors: Tim OWENS, Erik VERNER
  • Patent number: 9266895
    Abstract: The present disclosure provides compounds of Formula (IA) and or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: February 23, 2016
    Assignee: Principia Biopharma Inc.
    Inventors: Tim Owens, Erik Verner
  • Publication number: 20150291600
    Abstract: The present disclosure provides compounds that are JAK3 inhibitors and therefore useful for the treatment of diseases treatable by inhibition of JAK3 such as cancer and inflammatory diseases. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
    Type: Application
    Filed: November 19, 2013
    Publication date: October 15, 2015
    Inventors: David Michael Goldstein, Kenneth Albert Brameld, Tim Owens
  • Publication number: 20150094295
    Abstract: The present disclosure provides compounds of Formula (IA) and or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 6, 2013
    Publication date: April 2, 2015
    Inventors: Tim Owens, Erik Verner
  • Patent number: 8940744
    Abstract: The present disclosure provides compounds of Formula (IA) and/or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: August 20, 2014
    Date of Patent: January 27, 2015
    Assignee: Principia Biopharma Inc.
    Inventors: Tim Owens, Erik Verner
  • Publication number: 20140364410
    Abstract: The present disclosure provides compounds of Formula (IA) and/or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK, and are potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: August 20, 2014
    Publication date: December 11, 2014
    Inventors: Tim OWENS, Erik VERNER
  • Publication number: 20080027856
    Abstract: A computer implemented method and system for displaying and calculating a vehicle loan can include input fields for adjusting parameters associated with the vehicle loan. The system can provide selectable gauges that can be used to adjust parameters of the vehicle loan. The gauges can comprise analog displays that include an indicator, such as a needle or graphical blocks. The indicator can be selected and repositioned. The gauges can have a design, shape, and feel that resemble gauges of a vehicle, like an automobile. The gauges can display relative values that simulate relative values found in a vehicle, like an automobile. The system can comprise a three tier computer architecture with a computer server, a back-end system, and a client computer. In one exemplary embodiment, the software can run on the client computer and then access certain graphical files for the gauges that can be stored on the computer server.
    Type: Application
    Filed: July 26, 2006
    Publication date: January 31, 2008
    Applicant: LendingTree, LLC
    Inventors: Tim Owens, Erick Mick, Jennifer Blamy
  • Patent number: D825328
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: August 14, 2018
    Assignee: The Men's Wearhouse, Inc.
    Inventors: Doug Simpson, Rich Sullivan, Tim Owen
  • Patent number: D859517
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: September 10, 2019
    Inventors: Daniel B. Meyer, Stacy Foos, Tim Martin, Robert Martell, Ben Bruns, James Owen